Cite
Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations
MLA
Keyur P. Patel, et al. “Characteristics and Outcome of Chronic Myeloid Leukemia Patients with E255K/V BCR-ABL Kinase Domain Mutations.” International Journal of Hematology, vol. 107, no. 6, Nov. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e231aa5a0f0d5b75e51ec505ddc90eb6&authtype=sso&custid=ns315887.
APA
Keyur P. Patel, William G. Wierda, Sara Dellasala, Gautam Borthakur, Elias Jabbour, Raja Luthra, Tapan M. Kadia, Mary Beth Rios, Kiran Naqvi, Farhad Ravandi, Hagop M. Kantarjian, Guillermo Garcia-Manero, Jorge E. Cortes, Susan O’Brien, & Sherry Pierce. (2017). Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations. International Journal of Hematology, 107(6).
Chicago
Keyur P. Patel, William G. Wierda, Sara Dellasala, Gautam Borthakur, Elias Jabbour, Raja Luthra, Tapan M. Kadia, et al. 2017. “Characteristics and Outcome of Chronic Myeloid Leukemia Patients with E255K/V BCR-ABL Kinase Domain Mutations.” International Journal of Hematology 107 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e231aa5a0f0d5b75e51ec505ddc90eb6&authtype=sso&custid=ns315887.